Good Salt Life Expands Clean Republic Multipurpose Disinfectant Label with Hospital-Disinfectant Kill Claims
LOS ANGELES, CA, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in relapsed/refractory AL Amyloidosis, today announced that it will participate and host institutional investor meetings at the Morgan Stanley 24th Annual Global Healthcare Conference being held September 14-16, 2026 in New York, NY.
New York, New York--(Newsfile Corp. - August 4, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against BitGo Holdings, Inc. ("BitGo" or the "Company") (NYSE: BTGO) on behalf of all persons or entities who purchased or acquired: (a) BitGo Class A common stock in and/or traceable to BitGo's January 22, 2026 initial public offering ("IPO"); and/or (b) BitGo securities between January 22, 2026 and May 13, 2026 (the "Class Period").CLICK HERE TO JOIN THE...
San Francisco, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Q/C Technologies, Inc. (Nasdaq: QCLS) (“Q/C Technologies” or “the Company”), a developer of next-generation optical computing solutions, today announced the appointment of Yossef Ehrlichman, Ph.D. as Founding Manager, Photonic Integrated Circuit (PIC) Development.
New platform lets people and AI agents fund independent human review of mathematical proofs, scientific claims, simulations, code, and AI-generated research. SAN FRANCISCO, Aug. 4, 2026 /PRNewswire-PRWeb/ -- RigorLoop today announced the public launch of a funded research-review...
Silexion to present SIL-204 data at leading Cancer Symposium designed to feature the latest science in the field of GI cancers Silexion to present SIL-204 data at leading Cancer Symposium designed to feature the latest science in the field of GI cancers
LvlUp Ventures' MENA Global Investment Hub has backed over 50 startups and reviewed 500+ applications since its launch three months, advancing toward its goal of 250 companies by 2027.
New book offers a bold, practical vision for making healthcare more humane, efficient, and patient-centered.
(PR-inside.com) New offerings leverage Snowflake CoCo, Cortex AI, and phData's engineering expertise to help enterprises modernize analytics, accelerate migrations, deploy governed AI applications, and operationalize intelligent workflows faster. MINNEAPOLIS, MN / ACCESS Newswire / August 4, 2026 / phData, an AI and data services leader that builds intelligent systems for global enterprises, today announced an expanded strategic collaboration withSnowflake , the AI Data Cloud company, to help organizations move faster from AI experimentation to production. The collaboration brings together Snowflake's AI capabilities, including CoCo and Cortex AI, with phData's engineering expertise, delivery methodologies, and enterprise implementation experience to develop repeatable solutions that help
New offerings leverage Snowflake CoCo, Cortex AI, and phData's engineering expertise to help enterprises modernize analytics, accelerate migrations, deploy governed AI applications, and operationalize intelligent workflows faster.
Tuesday 4 August, 2026 Senior insurance executives, AI leaders, technology specialists and transformation experts will gather in New York on November 18–19 for Intelligent Insurer’s Agentic and Generative AI for Insurance USA conference, to explore how the industry can move from experimentation to scalable, enterprise-wide AI capabilities. Taking place at The Westin New York at Times Square, the two-day event will explore how insurers can move beyond promising pilots and embed agentic and generative AI into the enterprise infrastructure, operating models and workflows needed to deliver measurable business value. With more than 200 senior AI experts expected to attend, over 30 C-level speakers on the agenda and two dedicated tracks focused on use cases and enablement, the conference will pr
(PR-inside.com) HOCHDORF and Pharmalys announced on August 2, 2026, the launch of Hochdorf Laboratories SA, a new jointly owned company based in Hochdorf, Switzerland. The joint venture is led by HOCHDORF and marks an important step in the company's ongoing transformation, backed by its owner, AS Equity Partners. HOCHDORF, CH / ACCESS Newswire / August 4, 2026 / HOCHDORF and Pharmalys are proud to announce the official launch of a new, jointly owned company, Hochdorf Laboratories SA. This strategic joint venture (JV), led by HOCHDORF, is a key milestone in HOCHDORF's transformation, supported by its owner,AS Equity Partners. The JV combines HOCHDORF's world-class ..